MEDERGY HEALTHGROUP

medergy-healthgroup-logo

MedErgy HealthGroup provides evidence based communication solutions to biopharma, device, and diagnostic companies through the synergistic blend of our strategic, scientific, and creative skills.

#SimilarOrganizations #Financial #Website #More

MEDERGY HEALTHGROUP

Social Links:

Industry:
Health Care Pharmaceutical

Founded:
2002-01-01

Address:
Farnham, Surrey, United Kingdom

Country:
United Kingdom

Website Url:
http://www.cellohealthcommunications.com

Total Employee:
11+

Status:
Active

Contact:
+44 (0)1252 739194

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx JQuery CDN Digital Ocean


Similar Organizations

cegedimmedia-logo

CegedimMEDIA

Cegedim-MEDIA specializes in communication in pharmacies and drugstores.

pears-health-cyber-logo

Pears Health Cyber

Pears Health Cyber provides eSolutions for healthcare, pharma, and life sciences.

Acquisitions List

Date Company Article Price
2011-04-11 Red Kite Consulting Group Limited Red Kite Consulting Group Limited acquired by MedErgy HealthGroup N/A

Official Site Inspections

http://www.cellohealthcommunications.com

  • Host name: 167.99.83.61
  • IP address: 167.99.83.61
  • Location: London United Kingdom
  • Latitude: 51.5353
  • Longitude: -0.6658
  • Timezone: Europe/London
  • Postal: SL1

Loading ...

More informations about "MedErgy HealthGroup"

MedErgy HealthGroup - Crunchbase Company Profile & Funding

MedErgy HealthGroup provides evidence based communication solutions to biopharma, device, and diagnostic companies through the synergistic blend of our strategic, scientific, and …See details»

MedErgy Company Profile | Management and Employees List

MedErgy is the specialist global health care communications brand in the Cello Health group of companies. MedErgy HealthGroup Inc. is owned by Cello Group Inc., the US arm of Cello …See details»

Cello Group Boosts US Healthcare Market Exposure With MedErgy ...

Mar 15, 2011 · AIM listed marketing specialist Cello (LON:CLL) has agreed a deal to acquire MedErgy HealthGroup Inc., a healthcare communications consulting company based in …See details»

Cello Health Acquires MedErgy HealthGroup | Mergr M&A Deal …

On March 15, 2011, Cello Health acquired business services company MedErgy HealthGroup from Lake Capital and Frontenac for 15M USDSee details»

MedErgy HealthGroup Company Profile 2024: Valuation, Investors ...

MedErgy HealthGroup was acquired by Cello Health. Discover how our experts ensure you’re getting the most accurate financial data in the industry. Our data operations team has logged …See details»

MedErgy HealthGroup acquired by Cello Group - Crunchbase

Mar 15, 2011 · MedErgy HealthGroup MedErgy HealthGroup provides evidence based communication solutions to biopharma, device, and diagnostic companies. Acquiring …See details»

Cello Health - M&A Summary and Business Overview - Mergr

Cello Health has acquired 26 companies, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 2 assets. Cello Health’s largest acquisition …See details»

Our Story - Lumanity

Partnering with all 25 of the top 25 global pharma companies. Scientists, communicators, researchers, strategists, storytellers, and problem-solvers with work conducted in over 50 …See details»

Cello Health Communications strengthens its European efforts

May 18, 2017 · Cello Health Communications has rebranded its European communication services to align, expand and offer clients collaboration and deliver creative solutions. The iS …See details»

MedErgy HealthGroup, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for MedErgy HealthGroup, Inc. of Yardley, PA. Get the latest business insights from Dun & Bradstreet.See details»

SkillSets: Cello Health Communications - MM+M - Medical …

SkillSets Cello.pdf COMPANY PROFILE Cello Health Communications combines science, strategy and creativity to unlock evidence and drive differentiated engagement solutions for a …See details»

MedErgy HealthGroup Inc - Company Profile and News

Company profile page for MedErgy HealthGroup Inc including stock price, company news, executives, board members, and contact informationSee details»

Cello Health accelerates digital offering with new leadership

Aug 18, 2016 · Two key additions made to its US organisation’s digital offering.See details»

Cello Health Communications Accelerates its Digital Offering with …

Aug 17, 2016 · Thursday 22 February 2024 . twitter linkedin facebook rss. User account menu. Sign upSee details»

Cello Health Communications expands its European offerings

May 16, 2017 · Cello Health has announced the rebranding of its European communications offerings, iS Health Group and Cello Health Communications, Teddington. The objective of the …See details»

Cello Health Communications Revenue, Growth & Competitor Profile

Cello Health Communications's annual revenues are $10 - $100 million (see exact revenue data) What industry is the company in? Cello Health Communications is classified as operating in …See details»

Full article: Assessment of the Impact of Tardive Dyskinesia in ...

May 24, 2021 · Tardive dyskinesia (TD) is a hyperkinetic movement disorder in which patients experience abnormal involuntary movements that can have profound negative impacts on …See details»

Insights and Services of Cello Health Ltd | Course Hero

Jun 26, 2023 · Cello provides market research, consulting and direct marketing services. It provides services such as marketing advisory services to the global pharmaceutical, …See details»

Association Between Circulating GDF‐15 and Cardio‐Renal …

Dec 2, 2021 · We examined the association of baseline growth differentiation factor‐15 (GDF‐15), a marker of inflammation and cellular injury, with cardiovascular events, hospitalization for …See details»

582P Health-related quality of life (HRQoL) at final analysis of the ...

The phase II open-label GALAHAD study evaluated niraparib in mCRPC patients (pts) with DRD who had progressed on prior taxane-based chemotherapy and androgen signaling inhibitor …See details»

linkstock.net © 2022. All rights reserved